Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer.
| Last: | $4.175 |
|---|---|
| Change Percent: | -0.6% |
| Open: | $4.26 |
| Close: | $4.20 |
| High: | $4.4 |
| Low: | $3.93 |
| Volume: | 104,187 |
| Last Trade Date Time: | 02/27/2026 12:44:23 pm |
| Market Cap: | $47,188,867 |
|---|---|
| Float: | 5,977,256 |
| Insiders Ownership: | 0.74% |
| Institutions: | 24 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | www.cervomed.com |
| Country: | US |
| City: | Boston |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about CervoMed Inc. (NASDAQ: CRVO).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
